-
- Feb 21/26
Japan Approves World’s First iPS Therapies for Parkinson’s, Heart Failure - Feb 20/26
Key regulators of aging in male stem cells revealed - Feb 19/26
Japan panel approves world’s first iPS cell-based therapies - Feb 19/26
CGT Catapult establishes Technology Advisory Board to identify opportunities for the advanced therapies sector to deploy and benefit from innovations - Feb 19/26
Engineered CD4 CAR T cells reduce amyloid plaques in Alzheimer’s - Feb 19/26
“‘Cyborg’ pancreatic organoids revolutionize monitoring of islet cell maturation” - Feb 19/26
Next-generation bioelectronics interface with living ‘mini brains’ - Feb 19/26
Comprehensive bone marrow cell atlas advances leukemia research - Feb 19/26
Innovative vascularized tissueoid-on-a-chip model advances liver regeneration and transplant rejection research - Feb 18/26
Axol Bioscience acquires Newcells Biotech ophthalmology unit - Feb 18/26
Novel implant delivers tiny growth-promoting particles directly to injured nerve cells - Feb 18/26
Scaling up macrophage production with bioreactors - Feb 18/26
Michigan man gets new Roctavian gene therapy for hemophilia A - Feb 17/26
ExCellThera and Cordex Biologics’ Zemcelpro receives NUB programme status 1 in Germany - Feb 17/26
New Lund model aims to shorten the path to life-saving cell and gene therapies - Feb 17/26
Boehringer axes inhaled gene therapy after viewing cystic fibrosis data - Feb 17/26
A breakthrough discovery could help lungs repair themselves - Feb 16/26
MEDIPOST files IND amendment to FDA for Phase III osteoarthritis trial - Feb 15/26
Weekly reads: The Atlantic stem cell advertorial, Ozempic & cartilage restoration surprise, dwarfism tx - Feb 13/26
Global trends shape progress in cell and gene therapies - Feb 13/26
35 years of progress in cell and gene therapy - Feb 12/26
The role of AI in optimizing stem cell therapy for patients - Feb 12/26
UMass Chan licenses gene therapy for rare genetic disorder to Raiden Science Foundation - Feb 12/26
Unveiling AAV8’s complex degradation pathways - Feb 11/26
Early findings from first human study of in vivo CAR T in myeloma - Feb 11/26
FDA OKs risky, pioneering OSK rejuvenation trial with Sinclair’s ER-100 - Feb 10/26
Working group members appointed to the global workforce development in stem cell research and regenerative medicine initiative - Feb 10/26
Capsida confirms cause of death in clinical trial fatality for rare genetic disorder - Feb 10/26
REGENXBIO’s Hunter syndrome gene therapy fails to win FDA nod - Feb 9/26
Explainable AI reveals type 2 diabetes traits - Feb 9/26
First in-human study finds novel immune cell therapy is safe and effective in advanced lymphoma - Feb 9/26
Dana-Farber research advances lead to FDA label update for primary CNS lymphoma - Feb 9/26
Eli Lilly expands its in vivo ambitions, acquiring cell therapy startup Orna for up to $2.4B - Feb 9/26
Editing risk: Gene targets for lifelong cardiovascular disease prevention - Feb 9/26
Liver toxicities force pause on two dose groups of UniQure’s mid-stage Fabry study - Feb 8/26
Weekly reads: surprise Casgevy challenge, India bars stem cells for autism, Dorothy Bishop PubPeer analysis - Feb 7/26
Water pressure mechanism enables fast amoeboid cancer cell movement - Feb 6/26
Novel gene editing technique targets tumours overloaded with oncogenes - Feb 6/26
CAR T promises longer relief for myasthenia gravis - Feb 6/26
EAHAD 2026: Nine-year outcomes of gene therapy - Feb 6/26
New NK cell immune therapy targets hidden HIV reservoirs - Feb 5/26
Vertex sickle cell gene therapy stumbles due to slow blood cell collection from patients - Feb 5/26
Stem cell implants aim to restore dopamine in Parkinson’s disease - Feb 5/26
Human ILC1 cells fight leukemia stem growth - Feb 4/26
Could these two genes unleash the full power of T cells? - Feb 4/26
Wyoming stem cell bill is latest risky, anti-FDA state legislation - Feb 4/26
Two harmful variants can restore protein function - Feb 4/26
Enhancing ssDNA templates for CRISPR gene editing - Feb 3/26
UCLA scientists identify optimal design for off-the-shelf immunotherapy targeting solid tumours - Feb 3/26
George Coukos appointed director of new Ludwig Laboratory for Cell Therapy - Feb 2/26
5 critical challenges that biotech startups face in Canada - Feb 2/26
Inflammation ‘off-switch’ allows healing, prevents harmful immune response - Feb 2/26
Scientists identify key molecular trigger behind failed healing of certain broken bones - Feb 1/26
Creating bioactive human adipose matrix with CO2 - Feb 1/26
Weekly reads: human SCBEM framework, reporter self-injects peptides, ASD, NAMs - Feb 1/26
Lentiviral vectors revolutionize gene therapy techniques - Jan 30/26
Heart cells can regenerate, up to a point - Jan 30/26
Mesenchymal stem cells ease cerebral malaria via Tr17 - Jan 30/26
New CRISPR-based gene-editing treatment targets root cause of kidney disease - Jan 29/26
Engineered exosomes: A breakthrough in osteoporosis treatment - Jan 29/26
Muscle stem cells build resilience but lose regenerative power with age - Jan 29/26
Advancing bioengineered tooth regeneration: Clinical insights - Jan 29/26
Sensorion announces $71.9m reserved offering to expand gene therapy pipeline - Jan 29/26
Muscle RING finger-1 boosts skeletal muscle regeneration - Jan 28/26
Regenxbio gene therapy trials suspended by FDA over safety worries - Jan 28/26
Eli Lilly outlays $1.12bn for hearing loss gene therapy partnership - Jan 28/26
Efficacy of immunosuppressive regimens for survival of stem cell-derived grafts - Jan 28/26
Scientists develop first gene-editing treatment for skin conditions - Jan 28/26
Early type 1 diabetes alters CD4+ T cell profiles - Jan 27/26
Intellia gets FDA nod to resume gene therapy trial after safety pause - Jan 27/26
Centrifuge technique creates functional bioengineered lymph nodes - Jan 27/26
Gene therapy can restore hearing in some people born with congenital deafness - Jan 26/26
Gene therapy targeting connexin 43 shows promise across inherited heart diseases - Jan 26/26
Sarepta’s Duchenne gene therapy slows disease progression at three years - Jan 26/26
Designing powerful inhibitors for CRISPR-Cas13 - Jan 25/26
Weekly reads: NIH fetal tissue research ban, hESCs likely next, retraction spike, FDA CGT flexibility - Jan 25/26
Modeling bone regeneration with 3D-printed scaffolds - Jan 24/26
NK cell infusion shows promise in liver cancer trial - Jan 23/26
Rheumatologists view CAR T-cell therapy as ‘revolutionary,’ but cost, safety temper enthusiasm - Jan 23/26
Managing supply chain risk in scale-up and multisite trials - Jan 23/26
Nanorobots boost neural repair by guiding macrophages - Jan 23/26
Exosomes boost muscle repair by supporting progenitor cells - Jan 22/26
Antibody-linked stem cells target autoimmune diseases - Jan 22/26
FDA grants Orphan Drug Designation to BlueRock Therapeutics’ investigational cell therapy OpCT-001 - Jan 21/26
Gene therapy: A new solution to coronary graft failure? - Jan 21/26
Stem cells for stroke hype awardee 10 years ago now tells a cautionary tale - Jan 21/26
Novo Nordisk and Aspect Biosystems advance partnership for diabetes therapies - Jan 21/26
Report on effect of iPS cell culture medium on differentiation efficiency - Jan 20/26
CDMOs pin hopes for accelerating uptake at new US sites on FDA’s PreCheck program - Jan 20/26
Scientists solve a major roadblock holding back cancer cell therapy - Jan 19/26
AstraZeneca pens $630M pact to secure remaining rights to armoured CAR-T from AbelZeta - Jan 18/26
Unedited CD7 CAR-T cells show promise in T-cell leukemia - Jan 18/26
Textbooks were wrong: Human hair doesn’t grow the way scientists thought - Jan 18/26
Weekly reads: FDA politics, Lineage Cell update, tuft cells & cancer, neuron mitochondrial transfer, dead celeb genomics - Jan 17/26
Mitochondrial transfer: Dual impact on health and disease - Jan 16/26
Natural brakes on inflammation could treat chronic diseases - Jan 16/26
Chemical reprogramming transforms human T cells to pluripotency - Jan 15/26
Quantum tools set to transform life science, researchers say - Jan 15/26
Successful CAR T treatment for large B cell lymphoma may depend on circadian rhythms - Jan 14/26
New study explores therapeutic potential of CRISPR-Cas3 genome-editing system - Jan 14/26
Research spotlight: developing “smart” nanoparticles to deliver targeted gene therapy in osteoarthritis - Jan 14/26
Enhancing Kawasaki disease imaging with gold nanoparticles - Jan 13/26
Amsbio introduces AAV reference standards
- Feb 21/26
